Enterovirus Program

About Integrated Research Associates

Integrated Research Associates, founded in 2007, is a private biotechnology company operating in both therapeutic development and research reagents. Its core mission is to address unmet medical needs posed by neurovirulent and globally spreading viruses like dengue, Zika, and Japanese encephalitis through drug and vaccine R&D. The company has a dual business model, combining early-stage, pre-clinical therapeutic programs with a commercial portfolio of validated viral antigens and antibodies for the research community. This provides a revenue stream while funding its internal development efforts.

Therapeutic Areas